NAYA NAYA Biosciences Inc: Earnings per share for the trailing year

Public company logo of NAYA Biosciences Corp (NAYA)

The primary driver for NAYA Biosciences is the precision international delivery of oncology therapy components, which supports high margins. The year-over-year change in EPS (TTM) illustrates this trend, where the 0.00 level captures the latest values. The robotization of cell analysis accelerates drug discovery, while independence from macroeconomic factors transforms the company into a resilient defensive asset.

NAYA Biosciences Inc (NAYA): Earnings per share for the last twelve months from 02/11/2024 to 02/20/2024

Financial and market metric breakdowns for NAYA Biosciences Inc (NAYA)

- current quotes and average value forecast:
- company stock capitalization data:
Fundamental company valuation:NAYA - NAYA Bio
Mass-produced product of NAYA Biosciences Inc.

For NAYA Biosciences, which develops cancer immunotherapy methods, this indicator assesses the effectiveness of monetizing its developments. The metric measures the annual change in earnings per share, revealing the impact of operating expenses on final profitability. The current YoY net income per share growth over the last 12 months is 0.00. This chart reflects the risks of international clinical trial disruptions due to geopolitics. Negative values signal rising costs for biomaterials.

Direct competitors

Earnings per share for the trailing year ONC (BeiGene)|Halozyme Inc. (HALO) - Earnings per share for the last twelve months|RevMed - Earnings per share for the trailing year|AAPG (Ascentage Pharma Group International) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months CG Oncology, Inc. CGON|Net earnings per share for the last 12 months URGN (urogen.com)|Earnings per share for the last twelve months BCAX (Bicara Therapeutics)|Net earnings per share (EPS TTM) PSNL (personalis.com)|Earnings per share for the trailing year ERAS|DCTH - Earnings per share for the last twelve months|Y-mAbs Therapeutics (YMAB) - Net earnings per share for the last 12 months|AURA: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CADL|Earnings per share for the last twelve months Accuray Inc.|SELLAS Life Sciences Group (SLS) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months ACTU (Actuate Therapeutics, Inc)|Net earnings per share for the last four quarters Citius Oncology|TuHURA Biosciences, Inc. - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Protara TARA|fatetherapeutics.com - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aadi Bioscience|TCRX: Net earnings per share (EPS TTM)|CSBR - Net earnings per share for the last four quarters|XBIT (XBiotech) - Net earnings per share (EPS TTM)|CVM: Earnings per share for the trailing year|Net earnings per share (EPS TTM) OSTX|RADX (Radiopharm Theranostics Limited) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ARTV (Artiva Biotherapeutics, Inc.)|Earnings per share for the trailing year ANL|VERU: Net earnings per share for the last 12 months|TPST - Net earnings per share (EPS TTM)|XLO (xiliotx.com) - Net earnings per share for the last 12 months|Renovaro Biosciences - Earnings per share for the trailing year|Net earnings per share for the last 12 months MURA|Earnings per share for the last twelve months KAPA|Net earnings per share for the last 12 months OKUR (OnKure Therapeutics Inc)|Net earnings per share (EPS TTM) CytoMed (GDTC)|Earnings per share for the last twelve months curis.com CRIS|APLM (Apollomics, Inc.) - Earnings per one share for the last 12 months|Tharimmune Corporation - Net earnings per share (EPS TTM)|ADVB (advanbiomed.com) - Earnings per share for the last 12 months|Genprex, Inc (GNPX) - Earnings per share for the last twelve months|CLDI: Earnings per share for the last four quarters|SBFM (Sunshine Biopharma, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months XBIO (Xenetic Biosciences)|Net earnings per share (EPS TTM) SLRX|Purple Biotech - Earnings per share for the last 12 months|American Oncology Network - Net earnings per share for the last 12 months|Earnings per share for the trailing year BGNE|CKPT - Earnings per share for the last twelve months|Elevation Oncology (ELEV) - Net earnings per share for the last 12 months|ICAD: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Ikena Oncology Inc.|NTBL (Notable Labs Ltd) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Viracta Therapeutics (VIRX)|Earnings per share for the last twelve months MorphoSys Corporation (MOR)|AAPGV: Earnings per one share for the last 12 months